Hybrid Event

22nd - 23rd April 2025 | Munich, Germany

International Conference on Retinal Cell Biology and Advances in Ophthalmic Drugs (ICRCBAOD - 25)

96

Days

15

Hrs

07

Min

02

Sec

Call For Paper

Multidisciplinary Studies

  • Anti IL-6 therapy
    Corneal reshaping and transplantation
    Choroidal imaging
    Therapies in fighting blindness
    Translational research for periocular basal cell carcinoma and sebaceous cell carcinoma
    Impact of possitron emission tomography in ocular adnexae lymphoma
    Updates in management of thyroid eye disease
    Genetic eye diseases
    Advances in ophthalmic drug delivery systems
    Topical combination corticosteroid and anti-infective agents
    Transplantation technologies for retina
    Drugs used in the treatment of allergic conjunctivitis
    Oral and topical nonsteroidal anti-inflammatory agents NSAIDs
    Diagnostic dye solutions
    Ocular and systemic side effects of drugs
    IVT injection-sparing approaches
    Extended activity approaches
    Sustained delivery approaches
    Antibody dependent and antibody mediated diseases
    Cell mediated diseases
    Corneal graft reactions
    Fungal endophthalmitis
    Antibiotics in ocular infections
    Uveitis, intraocular inflammation
    Recent developments in immunotherapy
    Ocular refraction and therapeutics
    Community ophthalmology
    Eye and sorroundings disorders
    Investigation of corneal disease
    Corneal ulceration
    Epithelial keratitis and drug-induced epithelial keratitis
    Corneal degeneration
    Recurrent corneal erosion
    Miscellaneous corneal disorders
    Corneal neovascularization
    Pathophysiology of glaucoma
    Open-angle glaucoma
    Biomarkers for glaucoma
    Impaired ocular blood flow regulation in open angle glaucoma
    Endothelin in glaucoma treatment
    Complications and management of glaucoma filtering
    Closed-angle glaucoma